Emerging Role of PD-1 in the Central Nervous System and Brain Diseases

Junli Zhao1, Alexus Roberts2,3, Zilong Wang2

  • 1Department of Anesthesiology, Duke University Medical Center, Durham, 27710, USA. junli.zhao@duke.edu.

Neuroscience Bulletin
|April 20, 2021
PubMed

Insights

Programmed cell death protein 1 (PD-1) impacts the central nervous system (CNS), affecting immune responses and neuronal activity. Understanding PD-1 signaling in the brain offers new therapeutic strategies for neurological disorders.

Area of Science:

  • Neuroimmunology
  • Neuroscience
  • Immunology

Background:

  • Programmed cell death protein 1 (PD-1) is a key immune checkpoint target in cancer immunotherapy.
  • Emerging evidence highlights PD-1's significant role in central nervous system (CNS) functions and disorders.
  • PD-1 influences CNS immunity by modulating microglia and peripheral immune cells.

Purpose of the Study:

  • To explore the multifaceted roles of PD-1 signaling within the CNS.
  • To investigate PD-1's impact on both immune and neuronal functions in the brain.
  • To understand the cross-talk between glial cells, neurons, and immune cells mediated by PD-1.

Main Methods:

  • Review of existing literature on PD-1 in CNS disorders.
  • Analysis of PD-1 expression in neurons and glial cells.
  • Examination of downstream signaling pathways, including protein tyrosine phosphatase 1 and ion channel modulation.

Main Results:

  • PD-1 suppresses CNS immune responses.
  • PD-1 is expressed in neurons, where it suppresses neuronal activity.
  • PD-1 signaling involves glial cells, neurons, and peripheral immune cells.

Conclusions:

  • PD-1 plays a dual role in the CNS, affecting both immune and neuronal functions.
  • Further understanding of PD-1 signaling in the CNS is crucial for developing novel treatments.
  • Targeting PD-1 may offer new therapeutic avenues for brain diseases like tumors, Alzheimer's, and stroke.

Related Concept Videos

The Blood-brain Barrier00:49

The Blood-brain Barrier

Overview
50.5K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.1K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.1K
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
41.1K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
677